Health Catalyst, Inc. continues to navigate a complex market landscape as it maintains its position as a specialized provider of healthcare software solutions. Based in Salt Lake City, Utah, the company has carved out a niche in the healthcare sector by designing and delivering critical data management tools. Their software suite is engineered to assist hospitals in the efficient management of operational, financial, clinical, and research data—a vital function in an increasingly data-driven medical environment.

Despite the essential nature of its technological offerings, the company’s market performance reflects significant volatility. As of the close on November 16, 2026, Health Catalyst was trading at $1.37 on the Nasdaq. This valuation sits considerably below its 52-week high of $3.025, recorded in late November 2025, though it remains above its 52-week low of $0.955 seen in April 2026. With a market capitalization of approximately $105.86 million, the company remains a mid-cap player within the healthcare technology space.

The financial metrics present a challenging outlook for immediate-term investors. The company currently reports a price-to-earnings (P/E) ratio of -0.51, signaling ongoing efforts to reach sustained profitability amidst the high costs associated with software development and market expansion. While the company maintains a strong regional presence, particularly serving customers within the state of Utah, its ability to scale these specialized solutions to a broader national or international market will be the decisive factor in its long-term trajectory.

As the healthcare industry moves toward deeper integration of clinical and research data, Health Catalyst’s specialized focus on data efficiency positions it at a critical juncture. The company’s future success will depend on its ability to convert its technical capabilities into stabilized earnings and broader market penetration.